6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Helicobacter pylori ( H. pylori) infection is thought to impact various extragastric diseases, including nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease. Meanwhile, the pathogenesis of NAFLD needs further research, and effective treatment for this disease remains elusive. In this mini-review, we enumerate and ponder on the evidence demonstrating an association between H. pylori infection and NAFLD. Primarily, we delve into high-quality meta-analyses and clinical randomized controlled trials focusing on the association studies between the two. We also discuss clinical studies that present opposite conclusions. In addition, we propose a mechanism through which H. pylori infection aggravates NAFLD: inflammatory cytokines and adipocytokines, insulin resistance, lipid metabolism, intestinal barrier and microbiota, H. pylori outer membrane vesicles and H. pylori-infected cell-extracellular vesicles. This mini-review aims to further explore NAFLD pathogenesis and extragastric disease mechanisms caused by H. pylori infection.

          Related collections

          Most cited references109

          • Record: found
          • Abstract: not found
          • Article: not found

          The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Mendelian randomization: genetic anchors for causal inference in epidemiological studies

            Observational epidemiological studies are prone to confounding, reverse causation and various biases and have generated findings that have proved to be unreliable indicators of the causal effects of modifiable exposures on disease outcomes. Mendelian randomization (MR) is a method that utilizes genetic variants that are robustly associated with such modifiable exposures to generate more reliable evidence regarding which interventions should produce health benefits. The approach is being widely applied, and various ways to strengthen inference given the known potential limitations of MR are now available. Developments of MR, including two-sample MR, bidirectional MR, network MR, two-step MR, factorial MR and multiphenotype MR, are outlined in this review. The integration of genetic information into population-based epidemiological studies presents translational opportunities, which capitalize on the investment in genomic discovery research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanisms of NAFLD development and therapeutic strategies

              There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabetes and metabolic syndrome. NAFLD, a continuum of liver abnormalities from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), has a variable course but can lead to cirrhosis and liver cancer. Here we review the pathogenic and clinical features of NAFLD, its major comorbidities, clinical progression and risk of complications and in vitro and animal models of NAFLD enabling refinement of therapeutic targets that can accelerate drug development. We also discuss evolving principles of clinical trial design to evaluate drug efficacy and the emerging targets for drug development that involve either single agents or combination therapies intended to arrest or reverse disease progression.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2278765Role: Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1732575Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1306575Role: Role: Role:
                URI : https://loop.frontiersin.org/people/843447Role: Role: Role:
                Journal
                Front Cell Infect Microbiol
                Front Cell Infect Microbiol
                Front. Cell. Infect. Microbiol.
                Frontiers in Cellular and Infection Microbiology
                Frontiers Media S.A.
                2235-2988
                08 December 2023
                2023
                : 13
                : 1282956
                Affiliations
                [1] 1 Department of Gastroenterology, the Second Xiangya Hospital of Central South University , Changsha, Hunan, China
                [2] 2 Research Center of Digestive Diseases, Central South University , Changsha, Hunan, China
                [3] 3 Clinical Research Center, Digestive Diseases of Hunan Province , Changsha, Hunan, China
                Author notes

                Edited by: Leena Malayil, University of Maryland, College Park, United States

                Reviewed by: Giuseppe Losurdo, University of Bari Medical School, Italy

                Sasikala Muthusamy, Harvard Medical School, United States

                *Correspondence: Rong Li, xylulr@ 123456csu.edu.cn
                Article
                10.3389/fcimb.2023.1282956
                10739327
                38145041
                861a5505-021e-480e-9d11-69b3988b205a
                Copyright © 2023 Chen, Peng, Peng, Xiao, Liu and Li

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 25 August 2023
                : 21 November 2023
                Page count
                Figures: 1, Tables: 2, Equations: 0, References: 109, Pages: 11, Words: 6004
                Funding
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Natural Science Foundation of Hunan Province under Grant 211087206069.
                Categories
                Cellular and Infection Microbiology
                Review
                Custom metadata
                Bacteria and Host

                Infectious disease & Microbiology
                helicobacter pylori,extragastric disease,nonalcoholic fatty liver disease,meta-analysis,pathogenesis

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content756

                Cited by4

                Most referenced authors1,917